{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:39:20Z","timestamp":1792075160286,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"DOI":"10.7759\/cureus.43134","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T12:45:50Z","timestamp":1691498750000},"source":"Crossref","is-referenced-by-count":3,"title":["Clostridioides difficile Infection in Inflammatory Bowel Disease Patients: A Systematic Review of Risk Factors and Approach in Management"],"prefix":"10.7759","author":[{"given":"Leslie","family":"Sangurima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maujid Masood","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nency","family":"Ganatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Siby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doju","family":"Cheriachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.17597","article-title":"Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis","volume":"3","author":"Marra AR","year":"2020","unstructured":"Marra AR, Perencevich EN, Nelson RE, et al.. Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis. JAMA Netw Open. 2020, 3:e1917597. 10.1001\/jamanetworkopen.2019.17597","journal-title":"JAMA Netw Open"},{"key":"ref2","unstructured":"Clostridioides difficile Infection. (2019). Accessed. September 20, 2022: https:\/\/www.cdc.gov\/hai\/organisms\/cdiff\/cdiff_infect.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.12.027","article-title":"Incidence of Clostridium difficile infection in inflammatory bowel disease","volume":"5","author":"Rodemann JF","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007, 5:339-44. 10.1016\/j.cgh.2006.12.027","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20500","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"14","author":"Issa M","year":"2008","unstructured":"Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008, 14:1432-42. 10.1002\/ibd.20500","journal-title":"Inflamm Bowel Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly CR","year":"2021","unstructured":"Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021, 116:1124-47. 10.14309\/ajg.0000000000001278","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i39.4892","article-title":"Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship","volume":"16","author":"Navaneethan U","year":"2010","unstructured":"Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol. 2010, 16:4892-904. 10.3748\/wjg.v16.i39.4892","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.031","article-title":"Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection","volume":"7","author":"Ben-Horin S","year":"2009","unstructured":"Ben-Horin S, Margalit M, Bossuyt P, et al.. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection. Clin Gastroenterol Hepatol. 2009, 7:981-7. 10.1016\/j.cgh.2009.05.031","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan AN","year":"2008","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008, 57:205-10. 10.1136\/gut.2007.128231","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","unstructured":"Systematic reviews - research guide. (2023). Accessed. March 1, 2023: https:\/\/libguides.murdoch.edu.au\/systematic\/defining."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11070819","article-title":"The current knowledge on Clostridioides difficile infection in patients with inflammatory bowel diseases","volume":"11","author":"Boeriu A","year":"2022","unstructured":"Boeriu A, Roman A, Fofiu C, Dobru D. The current knowledge on Clostridioides difficile infection in patients with inflammatory bowel diseases. Pathogens. 2022, 11:819. 10.3390\/pathogens11070819","journal-title":"Pathogens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071315","article-title":"Risk factors, diagnosis, and management of Clostridioides difficile infection in patients with inflammatory bowel disease","volume":"10","author":"Del Vecchio LE","year":"2022","unstructured":"Del Vecchio LE, Fiorani M, Tohumcu E, et al.. Risk factors, diagnosis, and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Microorganisms. 2022, 10:1315. 10.3390\/microorganisms10071315","journal-title":"Microorganisms"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2020.00045","article-title":"Management of Clostridioides difficile infection in patients with inflammatory bowel disease","volume":"19","author":"Khanna S","year":"2021","unstructured":"Khanna S. Management of Clostridioides difficile infection in patients with inflammatory bowel disease. Intest Res. 2021, 19:265-74. 10.5217\/ir.2020.00045","journal-title":"Intest Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211020285","article-title":"The interplay of Clostridioides difficile infection and inflammatory bowel disease","volume":"14","author":"Sehgal K","year":"2021","unstructured":"Sehgal K, Yadav D, Khanna S. The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therap Adv Gastroenterol. 2021, 14:17562848211020285. 10.1177\/17562848211020285","journal-title":"Therap Adv Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001633","article-title":"Outcomes of fecal microbiota transplantation for C. difficile infection in inflammatory bowel disease: a systematic review and meta-analysis","volume":"57","author":"Tariq R","year":"2023","unstructured":"Tariq R, Syed T, Yadav D, et al.. Outcomes of fecal microbiota transplantation for C. difficile infection in inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2023, 57:285-93. 10.1097\/MCG.0000000000001633","journal-title":"J Clin Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i30.4378","article-title":"Regulation of the intestinal microbiota: an emerging therapeutic strategy for inflammatory bowel disease","volume":"26","author":"Yue B","year":"2020","unstructured":"Yue B, Yu ZL, Lv C, Geng XL, Wang ZT, Dou W. Regulation of the intestinal microbiota: an emerging therapeutic strategy for inflammatory bowel disease. World J Gastroenterol. 2020, 26:4378-93. 10.3748\/wjg.v26.i30.4378","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy143","article-title":"Risk factors associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis","volume":"13","author":"Balram B","year":"2019","unstructured":"Balram B, Battat R, Al-Khoury A, et al.. Risk factors associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2019, 13:27-38. 10.1093\/ecco-jcc\/jjy143","journal-title":"J Crohns Colitis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz061","article-title":"The juncture between Clostridioides difficile infection and inflammatory bowel diseases","volume":"69","author":"Beniwal-Patel P","year":"2019","unstructured":"Beniwal-Patel P, Stein DJ, Munoz-Price LS. The juncture between Clostridioides difficile infection and inflammatory bowel diseases. Clin Infect Dis. 2019, 69:366-72. 10.1093\/cid\/ciz061","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001394","article-title":"Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades","volume":"31","author":"Moens A","year":"2019","unstructured":"Moens A, Verstockt B, Machiels K, et al.. Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades. Eur J Gastroenterol Hepatol. 2019, 31:668-73. 10.1097\/MEG.0000000000001394","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy031","article-title":"Effect of faecal microbiota transplantation for treatment of Clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies","volume":"12","author":"Chen T","year":"2018","unstructured":"Chen T, Zhou Q, Zhang D, et al.. Effect of faecal microbiota transplantation for treatment of Clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies. J Crohns Colitis. 2018, 12:710-7. 10.1093\/ecco-jcc\/jjy031","journal-title":"J Crohns Colitis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000998","article-title":"Clostridium difficile infection and risk of colectomy in patients with inflammatory bowel disease: a bias-adjusted meta-analysis","volume":"23","author":"Chen Y","year":"2017","unstructured":"Chen Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, Kirk M. Clostridium difficile infection and risk of colectomy in patients with inflammatory bowel disease: a bias-adjusted meta-analysis. Inflamm Bowel Dis. 2017, 23:200-7. 10.1097\/MIB.0000000000000998","journal-title":"Inflamm Bowel Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i27.4986","article-title":"Management of inflammatory bowel disease with Clostridium difficile infection","volume":"23","author":"D'Aoust J","year":"2017","unstructured":"D'Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol. 2017, 23:4986-5003. 10.3748\/wjg.v23.i27.4986","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001414","article-title":"Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece","volume":"31","author":"Viazis N","year":"2019","unstructured":"Viazis N, Pontas C, Karmiris K, et al.. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece. Eur J Gastroenterol Hepatol. 2019, 31:773-6. 10.1097\/MEG.0000000000001414","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald LC","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, et al.. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018, 66:987-94. 10.1093\/cid\/ciy149","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02606-13","article-title":"Antibiotics for treatment of clostridium difficile infection in hospitalized patients with inflammatory bowel disease","volume":"58","author":"Horton HA","year":"2014","unstructured":"Horton HA, Dezfoli S, Berel D, et al.. Antibiotics for treatment of clostridium difficile infection in hospitalized patients with inflammatory bowel disease. Antimicrob Agents Chemother. 2014, 58:5054-9. 10.1128\/AAC.02606-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.02.018","article-title":"Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"14","author":"Khoruts A","year":"2016","unstructured":"Khoruts A, Rank KM, Newman KM, Viskocil K, Vaughn BP, Hamilton MJ, Sadowsky MJ. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2016, 14:1433-8. 10.1016\/j.cgh.2016.02.018","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/169682-clostridioides-difficile-infection-in-inflammatory-bowel-disease-patients-a-systematic-review-of-risk-factors-and-approach-in-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:04Z","timestamp":1707508924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/169682-clostridioides-difficile-infection-in-inflammatory-bowel-disease-patients-a-systematic-review-of-risk-factors-and-approach-in-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.43134","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}